These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

684 related articles for article (PubMed ID: 15545925)

  • 1. Inhibition of toll-like receptor and cytokine signaling--a unifying theme in ischemic tolerance.
    Karikó K; Weissman D; Welsh FA
    J Cereb Blood Flow Metab; 2004 Nov; 24(11):1288-304. PubMed ID: 15545925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms.
    Loppnow H; Werdan K; Buerke M
    Innate Immun; 2008 Apr; 14(2):63-87. PubMed ID: 18713724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toll-like receptor signaling and regulation of cytokine gene expression in the immune system.
    Ozato K; Tsujimura H; Tamura T
    Biotechniques; 2002 Oct; Suppl():66-8, 70, 72 passim. PubMed ID: 12395929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular and intracellular decoys in the tuning of inflammatory cytokines and Toll-like receptors: the new entry TIR8/SIGIRR.
    Mantovani A; Locati M; Polentarutti N; Vecchi A; Garlanda C
    J Leukoc Biol; 2004 May; 75(5):738-42. PubMed ID: 14673019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is targeting Toll-like receptors and their signaling pathway a useful therapeutic approach to modulating cytokine-driven inflammation?
    Andreakos E; Foxwell B; Feldmann M
    Immunol Rev; 2004 Dec; 202():250-65. PubMed ID: 15546398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of innate immune responses by Toll-like receptors.
    Takeda K; Akira S
    Jpn J Infect Dis; 2001 Dec; 54(6):209-19. PubMed ID: 11862002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression of toll-like receptors 3 and 7 in rheumatoid arthritis synovium is increased and costimulation of toll-like receptors 3, 4, and 7/8 results in synergistic cytokine production by dendritic cells.
    Roelofs MF; Joosten LA; Abdollahi-Roodsaz S; van Lieshout AW; Sprong T; van den Hoogen FH; van den Berg WB; Radstake TR
    Arthritis Rheum; 2005 Aug; 52(8):2313-22. PubMed ID: 16052591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toll-like receptors and the host defense against microbial pathogens: bringing specificity to the innate-immune system.
    Netea MG; van der Graaf C; Van der Meer JW; Kullberg BJ
    J Leukoc Biol; 2004 May; 75(5):749-55. PubMed ID: 15075354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulating toll-like receptor signalling as a novel antiinfective approach.
    Mbow ML; Sarisky RT
    Drug News Perspect; 2005 Apr; 18(3):179-84. PubMed ID: 15915219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interleukin-1 receptor/Toll-like receptor superfamily: signal transduction during inflammation and host defense.
    Dunne A; O'Neill LA
    Sci STKE; 2003 Feb; 2003(171):re3. PubMed ID: 12606705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered monocyte responses to defined TLR ligands in patients with primary biliary cirrhosis.
    Mao TK; Lian ZX; Selmi C; Ichiki Y; Ashwood P; Ansari AA; Coppel RL; Shimoda S; Ishibashi H; Gershwin ME
    Hepatology; 2005 Oct; 42(4):802-8. PubMed ID: 16175622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Function and mechanism of toll-like receptors in cerebral ischemic tolerance: from preconditioning to treatment.
    Wang PF; Xiong XY; Chen J; Wang YC; Duan W; Yang QW
    J Neuroinflammation; 2015 Apr; 12():80. PubMed ID: 25928750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-1 receptor/Toll-like receptor signaling in infection, inflammation, stress and neurodegeneration couples hyperexcitability and seizures.
    Vezzani A; Maroso M; Balosso S; Sanchez MA; Bartfai T
    Brain Behav Immun; 2011 Oct; 25(7):1281-9. PubMed ID: 21473909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory and neuroimmunomodulatory changes in acute cerebral ischemia.
    Brea D; Sobrino T; Ramos-Cabrer P; Castillo J
    Cerebrovasc Dis; 2009; 27 Suppl 1():48-64. PubMed ID: 19342833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution and integration of innate immune recognition systems: the Toll-like receptors.
    Takeda K
    J Endotoxin Res; 2005; 11(1):51-5. PubMed ID: 15826379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of cytokine production in human T cells and monocytes by highly purified lipoteichoic acid: involvement of Toll-like receptors and CD14.
    Ellingsen E; Morath S; Flo T; Schromm A; Hartung T; Thiemermann C; Espevik T; Golenbock D; Foster D; Solberg R; Aasen A; Wang J
    Med Sci Monit; 2002 May; 8(5):BR149-56. PubMed ID: 12011760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor necrosis factor alpha blockade treatment down-modulates the increased systemic and local expression of Toll-like receptor 2 and Toll-like receptor 4 in spondylarthropathy.
    De Rycke L; Vandooren B; Kruithof E; De Keyser F; Veys EM; Baeten D
    Arthritis Rheum; 2005 Jul; 52(7):2146-58. PubMed ID: 15986373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors.
    Takaoka A; Yanai H; Kondo S; Duncan G; Negishi H; Mizutani T; Kano S; Honda K; Ohba Y; Mak TW; Taniguchi T
    Nature; 2005 Mar; 434(7030):243-9. PubMed ID: 15665823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-like receptors in cerebral ischemic inflammatory injury.
    Wang YC; Lin S; Yang QW
    J Neuroinflammation; 2011 Oct; 8():134. PubMed ID: 21982558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.